Innovage Holding CORP 8-K filings

InnovAge Holding Corp. reaffirms its full-year fiscal 2026 guidance, as previously provided on May 5, 2026, in conjunction with its third-quarter earnings release.

InnovAge Holding Corp. announced the appointment of Jennifer Browne as President and Chief Operating Officer, effective June 8, 2026, bringing extensive experience in value-based care.

InnovAge Holding Corp. reaffirms its full year fiscal year 2026 guidance in anticipation of meetings with investors and analysts at the KeyBank Capital Markets Healthcare Forum.

InnovAge Holding Corp. announced strong fiscal second quarter 2026 financial results, reporting a significant return to profitability and raising its full fiscal year 2026 revenue and Adjusted EBITDA guidance.

InnovAge Holding Corp. announced the immediate appointment of Pavithra Mahesh and Sean Traynor to its Board of Directors, increasing the board size to eleven.

InnovAge Holding Corp. presented a robust growth trajectory and expanding profitability at its January 2026 investor conference, highlighting its unique PACE model for complex seniors.

InnovAge Holding Corp. announced the results of its 2025 Annual Meeting of Stockholders, including the election of three Class II directors and the ratification of Deloitte & Touche LLP as its independent auditor.

InnovAge Holding Corp. announced a strong start to fiscal 2026, reporting a significant increase in revenue and a return to profitability for its first quarter ended September 30, 2025.

InnovAge Holding Corp. announced the departure of President and Chief Operating Officer Michael Scarbrough, effective November 28, 2025.

InnovAge Holding Corp. announced robust financial results for fiscal year 2025, driven by significant revenue growth and improved Adjusted EBITDA, alongside increased participant census.

InnovAge Holding Corp. has successfully refinanced its existing term loan and revolving credit facilities, extending the maturity dates to August 8, 2028.

InnovAge reports a 13% increase in revenue and a significant rise in Adjusted EBITDA for the third fiscal quarter ended March 31, 2025, driven by topline growth and cost management.

InnovAge reports a 10.6% increase in total revenue for the second fiscal quarter ended December 31, 2024, but also a larger net loss compared to the same period last year.

InnovAge Holding Corp. held its 2024 Annual Meeting of Stockholders on December 5, 2024, where directors were elected, the appointment of an accounting firm was ratified, and an amendment to the company's charter was approved.

InnovAge Holding Corp. announced improved financial results for the first fiscal quarter ended September 30, 2024, with increased revenue and reduced losses.

InnovAge Holding Corp. has appointed Michael Scarbrough as its new President and Chief Operating Officer, and promoted Maria Lozzano to President, Pharmacy Services, effective November 4, 2024.

InnovAge Holding Corp. has increased its share repurchase program by $2.5 million, adding to the $5.0 million previously authorized in June 2024.

InnovAge Holding Corp. announced improved financial results for fiscal year 2024, with increased revenue and reduced losses, and provided optimistic financial guidance for fiscal year 2025.

InnovAge Holding Corp. has authorized a share repurchase program of up to $5 million of its common stock.

InnovAge Holding Corp. announced its financial results for the fiscal third quarter ended March 31, 2024, showing an 11.9% increase in total revenue compared to the same period last year.

InnovAge presented its growth strategy and financial outlook at its Investor Day, emphasizing its unique position in the PACE market and its potential for significant growth.

InnovAge Holding Corp. announced its fiscal second quarter results, showing revenue growth and improved profitability compared to the same period last year, while reaffirming its full-year financial guidance.